Inhaled budesonide for early treatment of COVID-19 - Authors' reply

Lancet Respir Med. 2021 Jul;9(7):e61. doi: 10.1016/S2213-2600(21)00212-5. Epub 2021 May 12.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Asthmatic Agents*
  • Budesonide
  • COVID-19*
  • Formoterol Fumarate
  • Humans
  • SARS-CoV-2

Substances

  • Anti-Asthmatic Agents
  • Budesonide
  • Formoterol Fumarate